A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...

A new experimental drug may offer hope for pancreatic cancer patients. One of deadliest types of cancer in the United States, an estimated 52,740 Americans will die from the disease this year, ...

Every year, more than 67,000 people are diagnosed with pancreatic cancer. In most cases, the disease has spread, and patients ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

The signs of pancreatic cancer are very subtle and often overlooked. Dr Sethi shares seven things to look out for to detect ...

Revolution Medicines has spent nearly a decade chasing what Dr. Alan Sandler, the Chief Development Officer at the company, ...

Lynch syndrome, an autosomal dominant disorder caused by defective DNA mismatch repair genes, is linked to early-onset colorectal, ovarian, gastric, urinary tract and, less commonly, small bowel, ...

As life expectancy rises and surgery becomes safer, India’s oldest patients are increasingly choosing to be active and ...